Syrma SGS Technology Ltd Q1 FY27 Earnings Call: Guides 30-35% Revenue Growth, Order Book Crosses Rs. 6,770 Cr

CompoundingAI Research Published July 31, 2026 7 min read

Syrma SGS Technology Ltd held its Q1 FY27 earnings call on July 29, 2026. Here's a quick read of what management said — performance, strategy, and the outlook ahead.

Headline Numbers

  • Revenue of Rs.1,604 crores — Q1 FY 2026-2027 consolidated revenue grew 67% YoY, with operating EBITDA up 69% to Rs.162 crores and PAT rising 112% to Rs.106 crores.
  • ODM revenue surged ~100% YoY — reached Rs.270 crores in Q1 FY 2026-2027 (from Rs.125 crores in Q1 FY 2025-2026), following 82% growth in FY 2025-2026 to Rs.825 crores.
  • Export revenue of Rs.387 crores — grew 61% YoY and represented 24% of total revenue in Q1 FY 2026-2027; geography mix: USA 22%, Europe 40%, balance other countries.
  • EBITDA margin of 10.1% — Q1 FY 2026-2027 margin was impacted by a higher consumer segment share of 34% vs. management's annualised target of ~30%.
  • Adjusted annualised ROCE of 20.1% — net cash position maintained at Rs.122 crores, with cash and investments exceeding Rs.800 crores.
  • Net working capital days widened to 71 — from 63 in the prior quarter, driven by strategic inventory build amid supply chain constraints.

Pipeline and Customer Growth

  • Order book of Rs.6,770 crores — as of Q1 FY 2026-2027 end, up from Rs.6,400 crores at Q4 FY 2025-2026, implying order intake of Rs.1,781 crores in the quarter; Rs.5,400 crores executable in the next 12 months.
  • 18 new customers onboarded — in Q1 FY 2026-2027, comprising auto (5), industrial (3), healthcare (2), and the balance in telecom, IT, and railways; expected to contribute from FY 2027-2028 with full ramp-up by FY 2028-2029.
  • New customers carry Rs.1,000+ crore potential — management estimates these 18 clients can generate incremental revenue of over Rs.1,000 crores on a full ramp-up basis, with margin profiles aligned to respective verticals.
  • Global wallet-share expansion over 5-7 years — management expects wallet share with global customers to slowly increase from 1-2% to 4-6%, noting that even a 2-4% share can represent a $50-100 million business.
  • Order book composition — automotive 29%, consumer 30%, industrial 24%, healthcare 7%, IT/railways 9%; average execution period of 10-10.5 months.
  • Domestic vs. export mix — current revenue split is approximately 75% domestic and 25% exports; for domestic customers, the company is typically the #1 or #2 vendor.

Vertical-Wise Breakdown

  • Consumer business at 34% of revenue — in Q1 FY 2026-2027, up from ~30% in the prior quarter; management targets a full-year consumer share of 30-32% due to seasonality. Automotive contributed 24%, industrial 24%, healthcare 7%, IT/railways 9%.
  • Healthcare segment order book of ~Rs.500 crore — covering healthcare RFID and MedTech, with two new clients onboarded for CDMO and design services; expected to be 7-8% of total business in FY 2026-2027.
  • Syrma Joyari MedTech guided ~50% growth — the subsidiary reported Rs.210 crore in FY 2025-2026; management expects ~50% growth in FY 2026-2027 due to a lower base.
  • Auto (EV, charging) grew strongly — healthcare up 100% YoY, consumer grew 68% (driven by telecom and water purification ODM), while smart metering was slightly lower and defense was subdued in Q1 FY 2026-2027.
  • Defense guided 30-35% growth — for FY 2026-2027, with management citing plans to "expand offerings beyond the existing Elcom portfolio over the next 3-5 years."
  • Industrial business (ex-defense maritime) of ~Rs.325 crore — flat sequentially in Q1 FY 2026-2027; growth drivers include new businesses like fuel industry systems and other utility metering beyond defense maritime.

Margin Bridge and Supply Chain Dynamics

  • FY 2026-2027 EBITDA margin guidance of 10.5-11% — reiterated by management, with Q1 FY 2026-2027 margin of 10.1% impacted by the higher consumer mix; management expects full-year consumer share to moderate to 30-32%.
  • Supply chain war room established — a dedicated team focused on critical items to mitigate bare PCB shortages; geopolitical issues in the Middle East are impacting specialty chemicals for PCB and component lead times.
  • Supply chain normalization expected by end of calendar 2026 — management noted that manufacturers and distributors expect normalization by Q3 FY 2026-2027; inventory will be treated as a strategic asset for the next 1-2 quarters.
  • Memory price increases fully pass-through — absolute margins are unaffected, but percentage margins may see a slight correction because the company does not earn a value-add markup on higher component costs.
  • Capacity utilisation at 65-70% — expansion ongoing in Bengaluru and Pune facilities; MedTech capacity being expanded in Jodhpur with new injection-moulding and SMT lines for incremental business expected from FY 2027-2028 onwards.
  • Management sees "no risk to achieving or exceeding the current FY 2026-2027 guidance at a micro level" — with the only imponderable being geopolitical escalation in West Asia that could disrupt global supply chains.

PCB, JV, ODM, and Exports

  • Kaga JV targeting Rs.300-500 crore turnover over 3-5 years — the 60%-owned JV with Japanese conglomerate Kaga provides exclusive EMS manufacturing in India for Kaga's domestic requirements, targeting automotive and white goods; management guided it "can generate Rs.300-500 crore in turnover on a long-term basis."
  • PCB project on track for Q4 FY27 power-on — building is 65-70% complete, equipment from October onwards, power-on scheduled for January-March 2027, commercial production expected by April 2027; Phase 2 and 3 towards end of 2027/early 2028.
  • PCB Phase 1 capex of ~Rs.400 crore — funded through Rs.100-130 crore already spent, internal accruals, debt (50-60% debt-to-equity), and a government CAPEX incentive of 50%; management sees no need for additional equity funding.
  • PCB EBITDA margins guided at 15-18% at full ramp-up — initially lower around 10% or less during the first year of operations (FY 2027-2028), with asset turnover expected at 1.5x on a gross basis once fully utilized.
  • Export growth guided 30-40% for FY 2026-2027 — targeting Rs.1,500-1,600 crores from ~Rs.1,200 crores in FY 2025-2026; ODM momentum expected to be maintained as MedTech and defense scale, with ODM long-term target of 25% of total sales (from 17% currently).
  • QIP enabling resolution of Rs.1,000 crores — board-approved with no immediate need, but management wants to be ready for investment opportunities in the sector (e.g., semicon); the company holds a treasury balance of Rs.800+ crores.
  • C-DAC approval for domestic server motherboard manufacturing — the company received approval to design and manufacture server motherboards domestically and is working with select clients; also entering the data center ecosystem (power management and cooling) via its Bangalore facility.

Guidance and Outlook

  • Revenue growth guidance of 30-35% for FY 2026-2027 — reiterated with expectations to "exceed" the guided figure; the same trajectory is expected to be maintained for FY 2027-2028 and FY 2028-2029.
  • Global clients ramping from FY 2027-2028 onward — clients onboarded in FY 2023-2024, FY 2024-2025, and FY 2025-2026 typically take two years to ramp, with meaningful revenue contribution expected from FY 2027-2028.
  • Management believes "the worst is behind the company" — and it is on track to become a recognized Indian global EMS company, with a structured internal five-year plan and a new CEO (Jaydeep Singh Barar, ex-McKinsey) strengthening ODM capabilities.
  • Key growth drivers for FY 2026-2027 — EV (new customer onboarding), auto charging, telecom, ODM water purification, IT assembly, and domestic motherboard manufacturing; the geopolitical shift of electronics supply chains away from China creates a favourable tailwind.
  • Semicon strategy remains cautious — management will not commit until a credible partner is identified, but remains focused on being part of the semicon supply chain within defined red lines; management noted that "only Micron and Renesas are present in India under ISM 1."
  • EcoVadis gold medal and SBTi commitment — EcoVadis ranked Syrma SGS in the top 5 percentile globally for ESG; the company has "signed up with SBTi to set emission reduction targets for the next 10 years" and has a dedicated president-level executive for ESG.
Share on X · LinkedIn · WhatsApp

Disclaimer: This earnings call summary is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.

Powered by CompoundingAI — AI research platform for Indian stocks, every claim cited from primary filings

Login Now